Trelegy Ellipta is a once-daily, single inhaler triple therapy from GSK, in collaboration with Innoviva, approved as a long-term maintenance treatment for certain patients with chronic obstructive ...

GSP 304 (tiotropium bromide) is a mist that Glenmark Pharmaceuticals is developing to widen the narrowed airways that are a hallmark of chronic obstructive pulmonary disease. Glenmark is working on ...

COPD is among the leading causes of death in industrialized countries, and new pharmacological treatments are being developed to help patients with this disease. But a spectrum of non-pharmacological ...

Hoping to increase awareness of an often-debilitating and misdiagnosed lung condition called nontuberculous mycobacterial (NTM) lung disease, the COPD Foundation is hosting a Facebook discussion on ...

Columnist Caroline Gainer had been searching for ways to improve her rest. Now, with help of her Fitbit, she's found her ...

The U.S. Food and Drug Administration (FDA) has approved Nucala (mepolizumab) as an add-on maintenance treatment for certain people with chronic obstructive pulmonary ...

Using e-cigarettes, often called vaping, significantly increases the risk of chronic obstructive pulmonary disease (COPD), a U.S. study suggests. People who used e-cigarettes, which are ...

Trying something new doesn’t always yield good results, which is why those of us with chronic obstructive pulmonary disease (COPD) need to vet any new device we may wish to try. I did my due diligence ...

March is a difficult month for me. I can relate to Bill Withers’ song “Ain’t No Sunshine.” The bleak winter months in southern West Virginia get me a little (or a lot) down. Those of us with chronic ...

The moment I reached the top of the stairs with an oxygen saturation of 92%, I was filled with elation and relief. Although this saturation level would be considered below normal for most people, I ...

A urine test developed in a dipstick format by Global Access Diagnostics helped not only distinguish between stable and exacerbation states among chronic obstructive pulmonary disease (COPD) patients ...